Anemia as a predictor of cardiovascular events in patients with elevated serum creatinine

Alexander M Walker1, Gary Schneider, Jason Yeaw

  • 1i3 Drug Safety, Auburndale, Massachusetts, Thousand Oaks, California, USA.

Insights

Anemia significantly increases cardiovascular disease risk in patients with chronic kidney disease. Lower hemoglobin levels correlate with higher rates of myocardial infarction and heart failure hospitalizations.

Area of Science:

  • Nephrology
  • Cardiology
  • Hematology

Background:

  • Patients with anemia and chronic kidney disease (CKD) face heightened cardiovascular disease (CVD) risks.
  • Previous studies were limited in scope, hindering detailed analysis of the anemia-CKD-CVD relationship.

Purpose of the Study:

  • To investigate the association between anemia and cardiovascular events in patients with elevated serum creatinine.
  • To quantify the risk of specific cardiovascular events and dialysis initiation in relation to hemoglobin levels.

Main Methods:

  • Utilized a large insurance database linked with laboratory values.
  • Included patients with elevated serum creatinine (women >1.2 mg/dl, men >1.4 mg/dl) from July 2000 to June 2003.
  • Employed multivariate Poisson regression to analyze hospitalization rates for myocardial infarction, coronary revascularization, unstable angina, stroke, congestive heart failure, and new dialysis onset across different hemoglobin (Hb) levels.

Main Results:

  • Anemic patients (Hb <12 g/dl) had a 2-5 times higher risk of myocardial infarction hospitalization compared to those with Hb 12.0-12.9 g/dl.
  • Lower Hb levels were associated with increased incidence of coronary revascularization.
  • Congestive heart failure risk was elevated in anemic patients, decreasing with rising Hb levels.
  • Anemia showed a modest increase (7-34%) in the risk of progression to dialysis.

Conclusions:

  • Anemia is a significant risk factor for cardiovascular disease in individuals with elevated serum creatinine.
  • Maintaining adequate hemoglobin levels may mitigate cardiovascular risks in CKD patients.
  • Findings highlight the critical interplay between anemia, CKD, and cardiovascular health.

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...
Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance01:25

Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance

In healthy individuals, serum creatinine levels remain stable due to a balance between its constant production—primarily from muscle metabolism—and renal excretion. Creatinine is freely filtered by the glomeruli, making it a valuable marker for estimating renal function. When the glomerular filtration rate (GFR) decreases, the kidneys can only eliminate less creatinine, causing serum levels to rise.Serum creatinine concentration is widely used to estimate creatinine clearance (Clcr), a...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...